# SAM #6912710440008

VA award for emergency Pluvicto and Lutathera radiopharmaceuticals

**Buyer:** VA 262 Network Contract Office 22
**Posted:** October 29, 2026
**Identifier:** 6912710440008
**NAICS:** 325412, 424210

The Department of Veterans Affairs awarded an emergency, one-month bridge order to support cancer care at the VA Greater Los Angeles Healthcare System.
- **Government buyer:** Department of Veterans Affairs; VA Greater Los Angeles Healthcare System; Network Contracting Office 22.
- **Awarded vendor and OEM:** **Novartis Pharmaceuticals Corporation**, identified as the sole authorized source listed in the VA NAC catalog.
- **Products requested:**
  - **Pluvicto** radiopharmaceutical radioligand therapy; quantity and part number not stated.
  - **Lutathera** radiopharmaceutical radioligand therapy; quantity and part number not stated.
- **Purpose and requirements:** Emergency bridge delivery to maintain continuity of cancer care while the longer-term order is finalized. The justification cites urgent patient-care needs and the medications’ proprietary, specialized nature.
- **Award amount:** $769,496.80. Per-injection prices are not provided.

[View original listing](https://sam.gov/opp/3d2029d5692e4eab9822ccac36bb5d18/view)